Her weight loss plan was life-changing for Daniell
Five-year tumour recurrence was also statistically significantly reduced, with 79%, 51%, and 31% recurrence in the 1-9, 10-15, and 16 NLN groups, respectively (Log-rank = 9.24, p = .001)
Previous real-world evidence studies have shown dulaglutide to be associated with greater treatment persistence and adherence compared with semaglutide QW, liraglutide, and exenatide QW [26,27,28,29]
The PROTECT trial will further examine the associations between maternal CGM metrics with type 2 diabetes outcomes so that appropriate TIRp and mean glucose targets can be established
Identification and characterization of PDGFR+ mesenchymal progenitors in human skeletal muscle